Litcius/Paper detail

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

Wanbo Tai, Xiujuan Zhang, Aleksandra Drelich, Juan Shi, Jason Hsu, Larry L. Luchsinger, Christopher D. Hillyer, Chien‐Te K. Tseng, Shibo Jiang, Lanying Du

2020Cell Research160 citationsDOIOpen Access PDF

Topics & Concepts

BiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)Messenger RNA2019-20 coronavirus outbreakSars virusReceptorComputational biologyGeneticsGeneInfectious disease (medical specialty)OutbreakDiseasePathologyMedicineSARS-CoV-2 and COVID-19 ResearchRNA Interference and Gene DeliveryAnimal Virus Infections Studies
A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 | Litcius